Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. As the global leader in complement biology and inhibition for more than 20 years
Alexion, a global biopharmaceutical company (NASDAQ: ALXN), is committed to all the communities we engage with including patients, caregivers and their families; our valued employees and future talent; our neighbors around the world; investors; patient organizations; suppliers; business partners ...
Alexion encourages diversity of backgrounds and ideas. We genuinely care for and respect each other, working together as a high-performing team to deliver extraordinary results while embracing different perspectives.
Our commitment to gender and ethnic diversity extends to all ranks within...
Alexion’s vision is to continuously raise the bar to deliver on patient expectations with solutions designed for them as people – meaning we want to take the time to understand their social and emotional lives, as well as their medical condition.
In 2019, we created STAR – Solutions To Acc...
March 30, 2020 - Alexion Pharmaceuticals (NASDAQ: ALXN), a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing medicines, re...
Serving Communities is a key pillar of Alexion’s CSR-STAR platform and one of the drivers of our company’s culture. Alexion collaborates with organizations around the world to provide employees an opportunity to give back to their local communities.
More than two dozen...